Abstract-Derangements in the production and degradation of reactive oxygen species (ROS) as well as nitric oxide (NO) have been implicated in cardiovascular diseases. We explored how supplementation with L-arginine, an NO synthase substrate, restores such derangements of ROS/NO systems in Dahl salt-sensitive, hypertensive (DS) rats. We detected an increase of NADPH oxidase activity, a key enzyme that produces superoxide, in the membrane fraction of the renal cortex derived from DS rats loaded with high salt for 4 weeks; high salt loading also remarkably increased urinary H 2 O 2 , 8-isoprostane, and thromboxane B 2 excretion and decreased plasma NO end products. These changes from high salt loading were counteracted by oral L-arginine supplementation. We further examined expression patterns of NADPH oxidase subunits in renal cortex derived from these animals. High salt loading increased gp91phox and p47phox but not p22phox or Rac1 or mRNA abundance, which were counteracted with L-arginine supplementation. Western blot analyses after subcellular fractionation revealed that L-arginine supplementation distinctly decreases membrane localization of p47phox protein, as it decreases total expression of Rac1 protein in DS rats with high salt loading. These results disclose that high salt loading causes a deficiency in available L-arginine amounts for NO synthases and induces NADPH oxidase activation in the renal cortex of DS rats, which L-arginine supplementation markedly restores. Since superoxide rapidly eliminates NO, which inhibits sodium reabsorption in the cortical collecting duct, superoxide production caused by upregulated NADPH oxidase activity in the renal cortex of high salt-loaded DS rats may accelerate sodium reabsorption and hypertension. Key Words: rats, Dahl Ⅲ arginine Ⅲ hypertension, sodium-dependent Ⅲ nitric oxide Ⅲ cardiovascular diseases R ecent studies have revealed significant associations between the pathogenesis of numerous cardiovascular diseases, including hypertensive states, and the increase in reactive oxygen species (ROS) and/or the decrease in nitric oxide (NO). [1][2][3] Complete understanding of such derangements in ROS/NO systems has been prevented by the fact that mammalian organs are provided with multiple layers of complicated enzymatic as well as nonenzymatic machineries that deal with ROS/NO. 4,5 Among such machineries, NADPH oxidase, which was originally known to produce a large amount of superoxide anion to kill bacteria in neutrophils, 6 has attracted much attention as a potentially important player in a wide array of cardiovascular disorders. Although NADPH oxidase in the nonphagocytic cells has been less well characterized, physiologically relevant low generation of ROS and neutrophillike expression of NADPH oxidase subunits is present in vascular tissues, 7,8 which is activated by pulsatile stretch, 9 platelet-derived growth factor, 10 and angiotensin II. 1,[11][12][13][14][15] These studies, when taken together, suggest that NADPH oxidase may exert broader actions in cardi...